LLS is now Blood Cancer United

The Leukemia and Lymphoma Society is now Blood Cancer United.

Blood Cancer United is an evolution—not a new beginning—that will help us meet our bold goal: to enable patients with blood cancer to gain more than one million years of life by 2040.

With the name Blood Cancer United, we can now reach more people who need us—people affected by all 100+ types of blood cancer.

Our mission is not changing. And we will continue to be a global leader in blood cancer—research, support, and advocacy.

Since we began in 1949, we’ve made tremendous strides for the blood cancer community. Some blood cancers can now be cured, and others can be managed as long-term chronic conditions. So, we measure our progress not just by cures, but by all the people who can live longer, more active lives after a blood cancer diagnosis.

Our Bold Goal

By 2040, Blood Cancer United will enable people with blood cancer to gain more than one million years of life.

This means more birthdays, more graduations, more cherished moments and memories with family and friends.

Help us spread this message of hope to our patients - You can endure the difficulty of cancer, and you never have to fight alone.

Facts about blood cancer:

• There are 1.6M people in the U.S. living with or in remission from leukemia, lymphoma, myeloma, MDS or MPNs 
• Blood cancers account for 39.0% of all cancers in the 20 years & under-age group.  Based on 2013-2017 data
• Approximately every 3 minutes, one person in the US is diagnosed with leukemia, lymphoma or myeloma
• Approximately every 9 minutes, someone in the US dies from a blood cancer. 
• Leukemia, lymphoma and myeloma are expected to cause the deaths of an estimated 57,750 people in the US in 2021.

Blood Cancer United's Impact:

• Blood Cancer United has helped advance more than 70% of the 110 blood cancer treatment approvals in the last 6 years.
• Since 1949, Blood Cancer United has contributed more than $1.8 billion to cancer research 
• In 2021, Blood Cancer United dedicated $35 million in new multi-year funding to support more than 260 active research programs
• The Patti Robinson Kaufmann First Connection® Program matched more than 2,000 patients with trained volunteers facing the same disease, helping to avert pandemic-related isolation. In addition, membership in the Blood Cancer United Community—our online social network—increased to more than 19,000 individuals. 
• In 2022, Blood Cancer United Information Specialists responded to approximately 26,000 inquiries from patients and caregivers.
• Blood Cancer United awarded 100 scholarships to young adult blood cancer survivors in 2022, and 105 scholarships in 2023.